Literature DB >> 30511098

A controlled inflammation and a regulatory immune system are associated with more favorable prognosis of progressive multifocal leukoencephalopathy.

Nobuo Sanjo1, Yurie Nose2, Yukiko Shishido-Hara3, Saneyuki Mizutani4, Yoshiki Sekijima5, Hitoshi Aizawa6, Toru Tanizawa7, Takanori Yokota2.   

Abstract

OBJECTIVE: In the present study, we analyzed the inflammatory profiles of brain tissues obtained from patients with progressive multifocal leukoencephalopathy (PML) due to John Cunningham (JC) virus infection to identify potential prognostic factors.
METHODS: The study included seven patients (two men, five women) who had been pathologically diagnosed with PML, and all of whom were HIV negative. Fixed brain samples were analyzed via hematoxylin and eosin (HE) staining and Klüver-Barrera (KB) staining. We then performed immunohistochemistry (IHC) specific to JC virus capsid proteins (VP1 and VP2/3) and lymphocyte surface markers (CD4, CD8, CD138, and PD-1).
RESULTS: The mean age at onset was 53.4, while the mean duration until biopsy/autopsy was 4.7 months. Four patients were included in the good prognosis (GP) group, while three were included in the poor prognosis (PP) group. Pathological analysis revealed a significantly larger number of CD4-positive T-cell infiltrations (P = .029) in the GP group, along with a preserved CD4:CD8 ratio. Larger numbers of CD138-positive plasma cells were also observed in the GP group (P = .029) than in the PP group. Linear regression analyses revealed a significant association between the numbers of CD138-positive plasma cells and PD-1-positive cells (R2 = 0.80).
CONCLUSIONS: Viral loads in the cerebrospinal fluid, a controlled inflammatory response mediated by CD4- and CD8-positive T cells, and plasma cells are associated with PML prognosis. Our findings further indicate that regulatory plasma cells may regulate inflammatory T-cell activity via a PD-1/PD-L1 immuno-checkpoint pathway, thereby protecting the uninfected brain from excessive immune-mediated damage during an active JC virus infection.

Entities:  

Keywords:  CD4:CD8 ratio; IRIS; JC virus; PML; Progressive multifocal leukoencephalopathy; Regulatory plasma cell

Mesh:

Year:  2018        PMID: 30511098     DOI: 10.1007/s00415-018-9140-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  38 in total

1.  HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy.

Authors:  D B Clifford; C Yiannoutsos; M Glicksman; D M Simpson; E J Singer; P J Piliero; C M Marra; G S Francis; J C McArthur; K L Tyler; A C Tselis; N E Hyslop
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

2.  Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy.

Authors:  Juan Berenguer; Pilar Miralles; Julio Arrizabalaga; Esteban Ribera; Fernando Dronda; Josu Baraia-Etxaburu; Pere Domingo; Manuel Márquez; Francisco J Rodriguez-Arrondo; Fernando Laguna; Rafael Rubio; José Lacruz Rodrigo; J Mallolas; Verónica de Miguel
Journal:  Clin Infect Dis       Date:  2003-04-02       Impact factor: 9.079

3.  Cellular and humoral immune response in progressive multifocal leukoencephalopathy.

Authors:  F Weber; C Goldmann; M Krämer; F J Kaup; M Pickhardt; P Young; H Petry; T Weber; W Lüke
Journal:  Ann Neurol       Date:  2001-05       Impact factor: 10.422

4.  Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.

Authors:  Simona Bossolasco; Giliola Calori; Francesca Moretti; Antonio Boschini; Davide Bertelli; Maurizio Mena; Simonetta Gerevini; Arabella Bestetti; Rosa Pedale; Serena Sala; Stefania Sala; Adriano Lazzarin; Paola Cinque
Journal:  Clin Infect Dis       Date:  2005-02-01       Impact factor: 9.079

5.  Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.

Authors:  E John Wherry; Joseph N Blattman; Kaja Murali-Krishna; Robbert van der Most; Rafi Ahmed
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

6.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

7.  Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals.

Authors:  R A Du Pasquier; J E Schmitz; J Jean-Jacques; Y Zheng; J Gordon; K Khalili; N L Letvin; I J Koralnik
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 8.  Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment.

Authors:  Françoise Gray; Céline Bazille; Homa Adle-Biassette; Jacqueline Mikol; Antoine Moulignier; Francesco Scaravilli
Journal:  J Neurovirol       Date:  2005       Impact factor: 2.643

9.  Expression of JC virus agnoprotein in progressive multifocal leukoencephalopathy brain.

Authors:  Yuki Okada; Hirofumi Sawa; Shuichi Endo; Yasuko Orba; Takashi Umemura; Hiroshi Nishihara; Alexandru C Stan; Shinya Tanaka; Hidehiro Takahashi; Kazuo Nagashima
Journal:  Acta Neuropathol       Date:  2002-05-24       Impact factor: 17.088

10.  Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy.

Authors:  R J Buckanovich; G Liu; C Stricker; S M Luger; E A Stadtmauer; S J Schuster; K Duffy; D Tsai; A Pruitt; D L Porter
Journal:  Ann Hematol       Date:  2002-07-12       Impact factor: 3.673

View more
  7 in total

1.  Checkpoint inhibitors and progressive multifocal leukoencephalopathy: friends of foes?

Authors:  Daniele Focosi; Marco Tuccori; Fabrizio Maggi
Journal:  Ann Transl Med       Date:  2019-12

2.  Novel Caspase-1 inhibitor CZL80 improves neurological function in mice after progressive ischemic stroke within a long therapeutic time-window.

Authors:  Ling Pan; Wei-Dong Tang; Ke Wang; Qi-Feng Fang; Meng-Ru Liu; Zhan-Xun Wu; Yi Wang; Sun-Liang Cui; Gang Hu; Ting-Jun Hou; Wei-Wei Hu; Zhong Chen; Xiang-Nan Zhang
Journal:  Acta Pharmacol Sin       Date:  2022-05-02       Impact factor: 6.150

3.  Progressive multifocal leukoencephalopathy in a patient with systemic sclerosis treated with methotrexate: A case report and literature review.

Authors:  Theodora Simopoulou; Vana Tsimourtou; Christina Katsiari; Marianna Vlychou; Dimitrios P Bogdanos; Lazaros I Sakkas
Journal:  J Scleroderma Relat Disord       Date:  2020-06-18

4.  Immune Reconstitution Syndrome After Nivolumab for Progressive Multifocal Leukoencephalopathy.

Authors:  Julien Haroche; Fleur Cohen Aubart; Karima Mokhtari; Danielle Seilhean; Neila Benameur; Matthieu Peyre; Ahmed Idbaih; Zahir Amoura
Journal:  Neurol Clin Pract       Date:  2021-06

5.  Overexpression of PD-1 on Peripheral Blood Lymphocytes in Patients with Idiopathic Pulmonary Arterial Hypertension and Its Association with High Viral Loads of Epstein-Barr Virus and Poor Clinical Parameters.

Authors:  Michał Tomaszewski; Ewelina Grywalska; Andrzej Tomaszewski; Piotr Błaszczak; Marcin Kurzyna; Jacek Roliński; Grzegorz Kopeć
Journal:  J Clin Med       Date:  2020-06-24       Impact factor: 4.241

6.  Inflammatory Cerebellar PML with a CD4/CD8 Ratio of 2.9 Showed a Favorable Prognosis in a Patient with Rheumatoid Arthritis.

Authors:  Ryusei Nishigori; Yoko Warabi; Yukiko Shishido-Hara; Kazuo Nakamichi; Yasuhiro Nakata; Takashi Komori; Eiji Isozaki
Journal:  Intern Med       Date:  2019-07-31       Impact factor: 1.271

Review 7.  Fifty Years of JC Polyomavirus: A Brief Overview and Remaining Questions.

Authors:  Abigail L Atkinson; Walter J Atwood
Journal:  Viruses       Date:  2020-09-01       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.